Copyright © 1999 by Institute of Pharmacology
Polish Academy of Sciences
Pol. J. Pharmacol., 1999, 51, 391-397
ISSN 1230-6002

Go to: Contents | Previous Article | Next Article | PJP - Home Page |


REVERSAL OF STRESS-INDUCED DEFICIT IN AGGRESSION BY MONOAMINE OXIDASE INHIBITORS
Grażyna Ossowska#, Bożena Klenk-Majewska, Zofia Danilczuk, Andrzej Wróbel, Iwona Żebrowska-Łupina
Department of Clinical Pharmacology, Medical University School, Jaczewskiego 8, PL 20-090 Lublin, Poland

Reversal of stress-induced deficit in aggression by monoamine oxidase inhibitors. G. OSSOWSKA, B. KLENK-MAJEWSKA, Z. DANILCZUK, A. WRÓBEL, I. ŻEBROWSKA-ŁUPINA. Pol. J. Pharmacol., 1999, 51, 391-397.

In the present study we investigated the effect of two monoamine oxidase (MAO) inhibitors: moclobemide (selective, reversible inhibitor of MAO - type A) or selegiline (selective irreversible inhibitor of MAO - type B) on electric footshock-induced fighting behavior in normal (unstressed) and chronically stressed (14 various stressors over 16 days) rats. In rats exposed to chronic stress the number of fighting attacks was reduced by about 75%. Prolonged (once a day, for 14 days) treatment with moclobemide (50 mg/kg/day) or selegiline (2 mg/kg/day) counteracted the deficit in aggression induced by chronic stress. The findings of the present study demonstrate that the selective MAO inhibitors, moclobemide and selegiline, protect against "behavioral depression" induced by the chronic stress similarly to other classes of antidepressant drugs.

Key words: MAO inhibitors, moclobemide, selegiline, footshock-induced fighting behavior, chronic stress, rats

  # correspondence
Back to: Top | PJP - Home Page |